Search Results - "Lubinga, Solomon"

Better together? costs of first-line chemoimmunotherapy for advanced non-small cell lung cancer by Kish, Jonathan, Liassou, Djibril, Hartman, John, Lubinga, Solomon J, Chopra, Dhruv, Feinberg, Bruce

“…Recent advances have created options for first-line (1L) treatment of advanced/metastatic non-small cell lung cancer (aNSCLC). The study objectives were to…”
Get full text

Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective by Coleman, Robert L., Lubinga, Solomon J., Shen, Qin, Walder, Lydia, Burton, Mark, Mathews, Cara

“…Dostarlimab in combination with carboplatin-paclitaxel (CP) improves progression-free survival in patients with primary advanced or recurrent endometrial…”
Get full text

Adverse event costs associated with first-line therapy for advanced non–small cell lung cancer in the United States: An analysis of clinical trials of immune checkpoint inhibitors by Stenehjem, David, Lubinga, Solomon J., Wu, Aozhou, Betts, Keith A.

“…BACKGROUND: Immune checkpoint inhibitors, such as pembrolizumab, nivolumab, and atezolizumab, have demonstrated substantial survival benefits in patients with…”
Get full text

Cost Effectiveness of Early Endovenous Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis in the United Kingdom by Babigumira, Joseph B., Black, Stephen A., Lubinga, Solomon J., Pouncey, Anna L.

“…Early clot removal using endovascular intervention aims to reduce post-thrombotic syndrome (PTS) following iliofemoral deep venous thrombosis (DVT). This may…”
Get full text

A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations by Watkins, David, Lubinga, Solomon J, Mayosi, Bongani, Babigumira, Joseph B

“…Rheumatic heart disease (RHD) prevalence and mortality rates remain especially high in many parts of Africa. While effective prevention and treatment exist,…”
Get full text

Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease by Zimmermann, Marita, Lubinga, Solomon J., Banken, Reiner, Rind, David, Cramer, Geri, Synnott, Patricia G., Chapman, Richard H., Khan, Sonya, Carlson, Josh

“…The gene therapy voretigene neparvovec (VN) is the first Food and Drug Administration–approved treatment for vision loss owing to the ultra-rare RPE65-mediated…”
Get full text

Cost-effectiveness of nivolumab in patients with NSCLC in the United States by Chaudhary, Mohammad A, Lubinga, Solomon J, Smare, Caitlin, Hertel, Nadine, Penrod, John R

“…To determine the lifetime cost-effectiveness of nivolumab vs docetaxel in advanced squamous and nonsquamous non-small cell lung cancer (NSCLC) following…”
Get full text

Perceptions of HIV and Safe Male Circumcision in High HIV Prevalence Fishing Communities on Lake Victoria, Uganda by Nevin, Paul E, Pfeiffer, James, Kibira, Simon P S, Lubinga, Solomon J, Mukose, Aggrey, Babigumira, Joseph B

“…In 2010, the Uganda Ministry of Health introduced its Safe Male Circumcision (SMC) strategy for HIV prevention with the goal of providing 4.2 million voluntary…”
Get full text

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States by Garrison, Louis P., Babigumira, Joseph, Tournier, Clément, Goertz, Hans-Peter, Lubinga, Solomon J., Perez, Edith A.

“…The APHINITY trial assessed the effectiveness and the safety of adding pertuzumab to trastuzumab and chemotherapy (THP) compared to trastuzumab and…”
Get full text

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda by Lubinga, Solomon J, Atukunda, Esther C, Wasswa-Ssalongo, George, Babigumira, Joseph B

“…In settings where home birth rates are high, prenatal distribution of misoprostol has been advocated as a strategy to increase access to uterotonics during the…”
Get full text

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda by Lubinga, Solomon J, Atukunda, Esther C, Wasswa-Ssalongo, George, Babigumira, Joseph B

“…The diagram shows the impact of the 10 most influential parameters on the incremental cost per DALY averted from a modified societal perspective…”
Get full text

Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda by Katusiime, Barbra, Semakula, Daniel, Lubinga, Solomon J

“…Background: Adverse Drug Reactions (ADRs) are an important contributor to patient morbidity and hospitalisation in Uganda. Under-reporting of ADRs may increase…”
Get full text

Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States by Polyzoi, Maria, Sandhu, Hera, Maervoet, Johan, Yuan, Yong, Chaudhary, Mohammad A, Varol, Nebibe, Lee, Adam, Dale, Peter, Jones, Cheryl, Lubinga, Solomon J, Penrod, John R

“…This economic analysis evaluated the cost-effectiveness of nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of platinum-doublet chemotherapy (PDC)…”
Get more information

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study by Willis, Connor, Bauer, Hillevi, Au, Trang H, Menon, Jyothi, Unni, Sudhir, Tran, Dao, Rivers, Zachary, Akerley, Wallace, Schabath, Matthew B, Badin, Firas, Sekhon, Ashley, Patel, Malini, Xia, Bing, Gustafson, Beth, Villano, John L, Thomas, John-Michael, Lubinga, Solomon J, Cantrell, Michael A, Brixner, Diana, Stenehjem, David

Get full text

Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non–Small-Cell Lung Cancer in the United States by Stenehjem, David D., Lubinga, Solomon J., Gupte-Singh, Komal, Zhang, Ying, Le, Trong Kim, Penrod, John R., Smith, Cardinale B.

“…In phase 3 clinical trials, nivolumab prolonged overall survival (OS) compared to chemotherapy in patients with previously treated advanced non–small-cell lung…”
Get full text

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study by Willis, Connor, Bauer, Hillevi, Au, Trang H, Menon, Jyothi, Unni, Sudhir, Tran, Dao, Rivers, Zachary, Akerley, Wallace, Schabath, Matthew B, Badin, Firas, Sekhon, Ashley, Patel, Malini, Xia, Bing, Gustafson, Beth, Villano, John L, Thomas, John-Michael, Lubinga, Solomon J, Cantrell, Michael A, Brixner, Diana, Stenehjem, David

“…Tumor mutational burden (TMB) is a potential biomarker to predict tumor response to immuno-oncology agents in patients with metastatic non-small cell lung…”
Get full text

Cost-utility and budget impact of methylene blue-treated plasma compared to quarantine plasma by Babigumira, Joseph B, Lubinga, Solomon J, Castro, Emma, Custer, Brian

“…Methylene blue and visible light treatment and quarantine are two methods used to reduce adverse events, mostly infections, associated with the transfusion of…”
Get full text

Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation by Babigumira, Joseph B, Lubinga, Solomon J, Jenny, Alisa M, Larsen-Cooper, Erin, Crawford, Jessica, Matemba, Charles, Stergachis, Andy

“…Poor access to essential medicines is common in many low- and middle-income countries, partly due to an insufficient and inadequately trained workforce to…”
Get full text

Study protocol: using a mobile phone-based application to increase awareness and uptake of sexual and reproductive health services among the youth in Uganda. A randomized controlled trial by Nuwamanya, Elly, Nuwasiima, Afra, Babigumira, Janet U, Asiimwe, Francis T, Lubinga, Solomon J, Babigumira, Joseph B

“…Several cost-effective programs are being implemented around the world that use mobile technology to improve Sexual and Reproductive Health (SRH) uptake and…”
Get full text

Impact of pharmacy worker training and deployment on access to essential medicines and health outcomes in Malawi: protocol for a cluster quasi-experimental evaluation by Lubinga, Solomon J, Jenny, Alisa M, Larsen-Cooper, Erin, Crawford, Jessica, Matemba, Charles, Stergachis, Andy, Babigumira, Joseph B

“…Access to essential medicines is core to saving lives and improving health outcomes of people worldwide, particularly in the low- and middle-income countries…”
Get full text